Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.36 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.36 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.31 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.31 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19506632 | 0.84 | HRH3 (0.35) | HRH3TSHRALDH1A1 | |
| SCHEMBL9621298 | 0.82 | MEN1 (0.36) | ATMHRH3TDP1TSHRALDH1A1 | |
| SCHEMBL11501574 | 0.81 | LMNA (0.36) | LMNACARM1PRMT6PRMT8ATM | |
| SCHEMBL736306 | 0.81 | LMNA (0.36) | LMNACARM1PRMT6PRMT8ATM | |
| SCHEMBL20332371 | 0.80 | ALDH1A1 (0.33) | LMNAATMHRH3TDP1TSHR | |
| SCHEMBL24891399 | 0.79 | HRH3 (0.39) | LMNACARM1PRMT6PRMT8ATM | |
| SCHEMBL3630893 | 0.79 | HRH3 (0.39) | LMNACARM1PRMT6PRMT8ATM | |
| SCHEMBL22342735 | 0.79 | HRH3 (0.39) | LMNACARM1PRMT6PRMT8ATM | |
| SCHEMBL135698 | 0.79 | HRH3 (0.39) | LMNACARM1PRMT6PRMT8ATM | |
| SCHEMBL12108497 | 0.79 | LMNA (0.35) | LMNACARM1PRMT6PRMT8ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3124490-A1 | HIGH STABILITY POLYIONIC LIQUID SALTS | Sigma-Aldrich Co. LLC (US) | 2017-02-01 | — | — | EP | disclosed |
| US-8481722-B2 | High stability polyionic liquid salts | SIGMA-ALDRICH CO. LLC (US) | 2013-07-09 | — | — | US | disclosed |
| US-20120083603-A1 | HIGH STABILITY POLYIONIC LIQUID SALTS | SIGMA-ALDRICH CO. LLC (US) | 2012-04-05 | — | — | US | disclosed |
| US-8097721-B2 | polycationic or polyanionic molecules; use as stationary phases in gas chromatography, and as a reagent in electrospray ionization-mass spectrometry (ESI-MS); thermal stability; tris(anion) such as tris(sulfonate) or tris(cation) groups such as imidazolium, pyrrolidinium, ammonium | SIGMA-ALDRICH CO. LLC (US) | 2012-01-17 | — | — | US | disclosed |
| US-20080210858-A1 | High Stability Polyionic Liquid Salts | SIGMA-ALDRICH CO. NEWCO INC. | 2008-09-04 | — | — | US | disclosed |
| WO-2008095069-A2 | HIGH STABILITY POLYIONIC LIQUID SALTS | SIGMA-ALDRICH CO. (US) | 2008-08-07 | — | — | WO | disclosed |
| US-4156603-A | COMPLEXED WITH A POLYFUNCTIONAL LEWIS BASE | EXXON RESEARCH & ENGINEERING CO. (US) | 1979-05-29 | — | — | US | disclosed |
| US-4152401-A | Chelated lithium aluminum compounds | EXXON RESEARCH & ENGINEERING CO. (US) | 1979-05-01 | — | — | US | disclosed |
| US-4147530-A | Reductions of inorganic substrates with chelated sodium hydridoaluminates or hydridoborates | EXXON RESEARCH & ENGINEERING CO. (US) | 1979-04-03 | — | — | US | disclosed |
| US-4094876-A | OIL AND FUEL ADDITIVES | EXXON RESEARCH & ENGINEERING CO. (US) | 1978-06-13 | — | — | US | disclosed |
| US-4088666-A | Reductions with chelated lithium hydridoaluminates or hydridoborates | EXXON RESEARCH & ENGINEERING CO. (US) | 1978-05-09 | — | — | US | disclosed |
| US-3933879-A | SEPARATIONS, CATALYTIC REACTIONS, REDUCTIONS, ELECTROCHEMISTRY | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080210858-A1 | High Stability Polyionic Liquid Salts | PUF60, POLI, PARG | LMNA 807/4885CARM1 3871/4885PRMT6 4403/4885 |
| US-20120083603-A1 | HIGH STABILITY POLYIONIC LIQUID SALTS | PUF60, POLI, PARG | LMNA 807/4885CARM1 3871/4885PRMT6 4403/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.